Healthcare -
Biotechnology - NASDAQ - US
$ 8.54
-0.813 %
$ 1.78 B
Market Cap
-19.86
P/E
BCRX - OPERATING EXPENSES
Operating Expenses BCRX - BioCryst Pharmaceuticals, Inc.
430 M
LAST VALUE
14.62%
2 YEAR CAGR
30.35%
5 YEAR CAGR
24.54%
10 YEAR CAGR